Moderna, Inc. (Nasdaq: MRNA) Rings The Nasdaq Stock Market Opening Bell in Celebration of IPO
Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, visits the Nasdaq MarketSite in Times Square in celebration of its initial public offering (IPO).
Format
JPEG
Source
Nasdaq, Inc.